An In-home Observational Study to Compare Infant Crying and Fussing Parameters Documented by the LENA Recorder With Those Documented Via Parental E-diaries

NCT ID: NCT03390348

Last Updated: 2018-08-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

12 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-11-22

Study Completion Date

2018-05-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a in-home observational study of 12 healthy term infants of ≤15 weeks of age to compare infant crying and fussing parameters documented by the LENA recorder with those documented via parental e-diaries

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Crying Fussy Infant (Baby)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LENA Recorder

Use of the LENA recorder to document crying and fussing

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy term infants, age ≤15 weeks
* Singleton infants (≥37 and ≤42 weeks gestation)
* Birth weight within normal range for gender and gestational age
* Informed consent from parent or legal guardian whose age is ≥18 years old
* Live in a household with reliable electronic communication capability (e.g. smart phone, computer, internet access)
* Infants who are breastfed and/or are consuming any commercial infant formula as a major nutrient source
* Parent's/guardian's English literacy sufficient to follow instructions and complete forms

Exclusion Criteria

Infants:

* Currently or within last 30 days prior to screening, participation in any other investigational studies
* Known to have current or previous illness/condition which could interfere with the study outcome, as per Investigator's clinical judgment

Parents/Guardians of infants:

* Known to have a significant medical condition (including during pregnancy) that might interfere with the study, as per Investigator's clinical judgment
* Inability to comply with study protocol, as per the Investigator's judgement
Maximum Eligible Age

15 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

LENA Foundation

UNKNOWN

Sponsor Role collaborator

ObvioHealth

INDUSTRY

Sponsor Role collaborator

Danone Asia Pacific Holdings Pte, Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Parth Shah, MD

Role: PRINCIPAL_INVESTIGATOR

Obvio Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

ObvioHealth

Orlando, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Dykstra JR, Sabatos-Devito MG, Irvin DW, Boyd BA, Hume KA, Odom SL. Using the Language Environment Analysis (LENA) system in preschool classrooms with children with autism spectrum disorders. Autism. 2013 Sep;17(5):582-94. doi: 10.1177/1362361312446206. Epub 2012 Jul 2.

Reference Type BACKGROUND
PMID: 22751753 (View on PubMed)

Canault M, Le Normand MT, Foudil S, Loundon N, Thai-Van H. Reliability of the Language ENvironment Analysis system (LENA) in European French. Behav Res Methods. 2016 Sep;48(3):1109-24. doi: 10.3758/s13428-015-0634-8.

Reference Type RESULT
PMID: 26174716 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EBB17GC16811

Identifier Type: OTHER

Identifier Source: secondary_id

OBVIO-DAN-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Acupuncture in Infantile Colic
NCT00860301 COMPLETED NA
The Effect of Reading Therapy on Newborns
NCT05004857 ACTIVE_NOT_RECRUITING NA